首页 > 最新文献

Pakistan Journal of Medical Sciences最新文献

英文 中文
Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance. 阿帕替尼联合表皮生长因子受体-酪氨酸激酶抑制剂(表皮生长因子受体-TKI)治疗表皮生长因子受体-TKI耐药的非小细胞肺癌的临床疗效。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9682
Ruifen Tian, Yi Guo, Xing Zhang, Xia Zhang, Xia Song

Objective: To evaluate the efficacy and safety of Apatinib combined with epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in the treatment of patients with non-small cell lung cancer (NSCLC) and acquired EGFR-TKI resistance.

Methods: Clinical records of 106 patients with NSCLC at Shanxi Tumor Hospital of the Chinese Academy of Medical Sciences Cancer Hospital from January 2017 to October 2020, with acquired drug resistance after EGFR-TKI treatment were retrospectively analyzed. Among them, 52 patients received Apatinib combined with EGFR-TKI (Apatinib group), and 54 patients received a standard chemotherapy (pemetrexed combined with platinum) (chemotherapy group). Clinical efficacy indicators, follow-up results, and adverse reactions in both groups were compared.

Results: There was no significant difference in the objective response rate and disease control rate between the two groups (P>0.05). The progression free survival (PFS) of the Apatinib group was significantly longer than that of the chemotherapy group (10.5 months vs. 5.7 months; P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05).

Conclusions: Compared with standard chemotherapy, Apatinib combined with EGFR-TKI has the same efficacy in treating NSCLC patients with EGFR-TKI resistance, and was associated with longer PFS with no significant increase in adverse reactions.

目的评价阿帕替尼联合表皮生长因子受体-酪氨酸激酶抑制剂(EGFR-TKI)治疗获得性EGFR-TKI耐药的非小细胞肺癌(NSCLC)患者的疗效和安全性:回顾性分析中国医学科学院肿瘤医院山西肿瘤医院2017年1月至2020年10月106例经EGFR-TKI治疗后获得性耐药的NSCLC患者的临床病历。其中,52例患者接受阿帕替尼联合EGFR-TKI治疗(阿帕替尼组),54例患者接受标准化疗(培美曲塞联合铂类药物)(化疗组)。比较了两组患者的临床疗效指标、随访结果和不良反应:结果:两组患者的客观反应率和疾病控制率无明显差异(P>0.05)。阿帕替尼组的无进展生存期(PFS)明显长于化疗组(10.5个月 vs. 5.7个月;PP>0.05):与标准化疗相比,阿帕替尼联合表皮生长因子受体-TKI治疗表皮生长因子受体-TKI耐药的NSCLC患者疗效相同,且PFS更长,不良反应无明显增加。
{"title":"Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance.","authors":"Ruifen Tian, Yi Guo, Xing Zhang, Xia Zhang, Xia Song","doi":"10.12669/pjms.40.8.9682","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9682","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of Apatinib combined with epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in the treatment of patients with non-small cell lung cancer (NSCLC) and acquired EGFR-TKI resistance.</p><p><strong>Methods: </strong>Clinical records of 106 patients with NSCLC at Shanxi Tumor Hospital of the Chinese Academy of Medical Sciences Cancer Hospital from January 2017 to October 2020, with acquired drug resistance after EGFR-TKI treatment were retrospectively analyzed. Among them, 52 patients received Apatinib combined with EGFR-TKI (Apatinib group), and 54 patients received a standard chemotherapy (pemetrexed combined with platinum) (chemotherapy group). Clinical efficacy indicators, follow-up results, and adverse reactions in both groups were compared.</p><p><strong>Results: </strong>There was no significant difference in the objective response rate and disease control rate between the two groups (<i>P</i>>0.05). The progression free survival (PFS) of the Apatinib group was significantly longer than that of the chemotherapy group (10.5 months vs. 5.7 months; <i>P</i><0.05). There was no significant difference in adverse reactions between the two groups (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>Compared with standard chemotherapy, Apatinib combined with EGFR-TKI has the same efficacy in treating NSCLC patients with EGFR-TKI resistance, and was associated with longer PFS with no significant increase in adverse reactions.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of probiotics combined with Ulinastatin and Somatostatin in the treatment of severe acute pancreatitis. 益生菌联合乌司他丁和索马他丁治疗重症急性胰腺炎的效果。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9744
Hehe Dou, Yue Kan, Zhipeng Xu, Zhenjie Wang, Chuanming Zheng

Objective: To evaluate the clinical effect of probiotics combined with Ulinastatin and Somatostatin in the treatment of severe acute pancreatitis.

Methods: A retrospective study was conducted on 160 patients with severe acute pancreatitis treated in the First Affiliated Hospital of Bengbu Medical College from July 2021 to June 2023. There were 78 patients received Ulinastatin and Somatostatin treatment (Control group), and 82 patients received probiotics in addition to Ulinastatin and Somatostatin treatment (Observation group). The treatment effect and the time required to alleviate clinical symptoms were compared between the two groups. Serum levels of inflammatory factors, intestinal mucosal indexes and the incidence of adverse reactions before and after treatment were analyzed.

Results: The total efficacy of the Observation group (95.12%) was higher than that of the Control group (85.90%) (P<0.05). Combined probiotic/Ulinastatin + Somatostatin treatment was associated with shorter time to remission of the clinical symptoms (P<0.05). After the treatment, serum levels of inflammatory factors in the two groups were decreased, and was significantly lower in the Observation group compared to the Control group (P<0.05). Similarly, post-treatment serum levels of intestinal mucosal indexes in the two groups were lower than before the treatment, and significantly lower in the Observation group (P<0.05). There was no significant difference in the incidence of adverse reactions between the groups (P>0.05).

Conclusions: A combined regimen of probiotics, Ulinastatin and Somatostatin is safe and can more effectively relieve clinical symptoms in patients with severe acute pancreatitis, reduce levels of inflammatory factors, lower intestinal mucosal damage and improve the overall treatment effect compared to Ulinastatin and Somatostatin regimen alone.

目的评估益生菌联合乌利那他汀和索马他汀治疗重症急性胰腺炎的临床效果:方法:对 2021 年 7 月至 2023 年 6 月期间在蚌埠医学院第一附属医院接受治疗的 160 例重症急性胰腺炎患者进行回顾性研究。其中78例患者接受了乌司他丁和索马他丁治疗(对照组),82例患者在乌司他丁和索马他丁治疗的基础上接受了益生菌治疗(观察组)。比较了两组的治疗效果和缓解临床症状所需的时间。对治疗前后的血清炎症因子水平、肠粘膜指数和不良反应发生率进行了分析:结果:观察组的总有效率(95.12%)高于对照组(85.90%)(PPPPP>0.05):益生菌、乌利那他汀和索马他汀联合治疗方案安全,与单独使用乌利那他汀和索马他汀方案相比,能更有效地缓解重症急性胰腺炎患者的临床症状,降低炎症因子水平,减轻肠黏膜损伤,提高整体治疗效果。
{"title":"Effect of probiotics combined with Ulinastatin and Somatostatin in the treatment of severe acute pancreatitis.","authors":"Hehe Dou, Yue Kan, Zhipeng Xu, Zhenjie Wang, Chuanming Zheng","doi":"10.12669/pjms.40.8.9744","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9744","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical effect of probiotics combined with Ulinastatin and Somatostatin in the treatment of severe acute pancreatitis.</p><p><strong>Methods: </strong>A retrospective study was conducted on 160 patients with severe acute pancreatitis treated in the First Affiliated Hospital of Bengbu Medical College from July 2021 to June 2023. There were 78 patients received Ulinastatin and Somatostatin treatment (Control group), and 82 patients received probiotics in addition to Ulinastatin and Somatostatin treatment (Observation group). The treatment effect and the time required to alleviate clinical symptoms were compared between the two groups. Serum levels of inflammatory factors, intestinal mucosal indexes and the incidence of adverse reactions before and after treatment were analyzed.</p><p><strong>Results: </strong>The total efficacy of the Observation group (95.12%) was higher than that of the Control group (85.90%) (<i>P</i><0.05). Combined probiotic/Ulinastatin + Somatostatin treatment was associated with shorter time to remission of the clinical symptoms (<i>P</i><0.05). After the treatment, serum levels of inflammatory factors in the two groups were decreased, and was significantly lower in the Observation group compared to the Control group (<i>P</i><0.05). Similarly, post-treatment serum levels of intestinal mucosal indexes in the two groups were lower than before the treatment, and significantly lower in the Observation group (<i>P</i><0.05). There was no significant difference in the incidence of adverse reactions between the groups (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>A combined regimen of probiotics, Ulinastatin and Somatostatin is safe and can more effectively relieve clinical symptoms in patients with severe acute pancreatitis, reduce levels of inflammatory factors, lower intestinal mucosal damage and improve the overall treatment effect compared to Ulinastatin and Somatostatin regimen alone.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of a subanesthetic dose of esketamine combined with propofol on postoperative fatigue syndrome in patients undergoing gastroenterological endoscopy under anaesthesia: A retrospective study. 亚麻醉剂量的艾司卡胺联合异丙酚对麻醉下接受消化内镜检查的患者术后疲劳综合征的影响:一项回顾性研究。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9883
Guofang Fei, Wei Yan, Yuehua Gan

Objective: To assess the effect of subanesthetic dose of esketamine in combination with propofol on the incidence of postoperative fatigue syndrome (POFS) in patients who underwent gastroenterological endoscopy under anaesthesia.

Methods: Clinical data of 160 patients who underwent gastroenterological endoscopy under anaesthesia in Huzhou Maternity & Child Health Care Hospital from January to December 2022, ASA Grade- I and II, were retrospectively selected. According to the records, patients were grouped based on the administered anesthetic. Patients who received 0.2 mg/kg of esketamine and 2~2.5mg/kg of propofol comprised Group-E, and patients who were administered one μg/kg of fentanyl and 2 - 2.5mg/kg of propofol comprised Group-F. Mean arterial pressure (MAP), oxygen saturation (SpO2) and heart rate (HR) were recorded before the operation (T0), after anesthesia (T1), three minutes after the gastroscope was inserted (T2), five minutes after the colonoscope was inserted (T3) and at the end of the operation (T4). Operating time, recovery time, propofol dosage and incidence of adverse reactions in the two groups were recorded. The Christensen scores and the incidence of POFS of all patients on Day-I before operation and 1st, 3rd, and 5th days after the operation were recorded.

Results: Compared with T0, MAP, SpO2 and HR in both groups of patients decreased at T1, T2, T3 and T4 (P<0.05). MAP, SpO2 and HR of patients in Group-E were significantly higher compared to Group-F at T1, T2, T3 and T4 (P<0.05). Compared with Group-F, the recovery time, intraoperative bradycardia and respiratory depression in Group-E were significantly lower (P<0.05), and Christensen scores and the incidence of POFS decreased significantly on the 1st, 3rd, and 5th day after the operation (P<0.05).

Conclusion: Subanesthetic dose of esketamine combined with propofol can reduce POFS and postoperative adverse reactions in patients undergoing gastroenterological endoscopy.

目的评估亚麻醉剂量的艾司卡胺联合异丙酚对麻醉下消化内镜检查患者术后疲劳综合征(POFS)发生率的影响:方法:回顾性选取2022年1月至12月在湖州市妇幼保健院麻醉下接受消化内镜检查的160例ASA分级为Ⅰ级和Ⅱ级的患者的临床资料。根据病历记录,按照麻醉剂的剂量对患者进行分组。使用0.2毫克/千克艾司卡胺和2~2.5毫克/千克丙泊酚的患者为E组,使用1微克/千克芬太尼和2~2.5毫克/千克丙泊酚的患者为F组。记录了手术前(T0)、麻醉后(T1)、插入胃镜三分钟后(T2)、插入结肠镜五分钟后(T3)和手术结束时(T4)的平均动脉压(MAP)、血氧饱和度(SpO2)和心率(HR)。记录了两组的手术时间、恢复时间、异丙酚用量和不良反应发生率。记录所有患者术前第 I 天、术后第 1 天、第 3 天和第 5 天的 Christensen 评分和 POFS 发生率:结果:与 T0 相比,两组患者的 MAP、SpO2 和 HR 在 T1、T2、T3 和 T4 均有所下降(P2),E 组患者的 HR 在 T1、T2、T3 和 T4 均明显高于 F 组(PPPConclusion):亚麻醉剂量的艾司卡胺联合异丙酚可减少胃肠镜检查患者的 POFS 和术后不良反应。
{"title":"Effect of a subanesthetic dose of esketamine combined with propofol on postoperative fatigue syndrome in patients undergoing gastroenterological endoscopy under anaesthesia: A retrospective study.","authors":"Guofang Fei, Wei Yan, Yuehua Gan","doi":"10.12669/pjms.40.8.9883","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9883","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effect of subanesthetic dose of esketamine in combination with propofol on the incidence of postoperative fatigue syndrome (POFS) in patients who underwent gastroenterological endoscopy under anaesthesia.</p><p><strong>Methods: </strong>Clinical data of 160 patients who underwent gastroenterological endoscopy under anaesthesia in Huzhou Maternity & Child Health Care Hospital from January to December 2022, ASA Grade- I and II, were retrospectively selected. According to the records, patients were grouped based on the administered anesthetic. Patients who received 0.2 mg/kg of esketamine and 2~2.5mg/kg of propofol comprised Group-E, and patients who were administered one μg/kg of fentanyl and 2 - 2.5mg/kg of propofol comprised Group-F. Mean arterial pressure (MAP), oxygen saturation (SpO<sub>2</sub>) and heart rate (HR) were recorded before the operation (T<sub>0</sub>), after anesthesia (T<sub>1</sub>), three minutes after the gastroscope was inserted (T<sub>2</sub>), five minutes after the colonoscope was inserted (T<sub>3</sub>) and at the end of the operation (T<sub>4</sub>). Operating time, recovery time, propofol dosage and incidence of adverse reactions in the two groups were recorded. The Christensen scores and the incidence of POFS of all patients on Day-I before operation and 1st, 3rd, and 5th days after the operation were recorded.</p><p><strong>Results: </strong>Compared with T<sub>0</sub>, MAP, SpO<sub>2</sub> and HR in both groups of patients decreased at T<sub>1</sub>, T<sub>2</sub>, T<sub>3</sub> and T<sub>4</sub> (<i>P</i><0.05). MAP, SpO<sub>2</sub> and HR of patients in Group-E were significantly higher compared to Group-F at T<sub>1</sub>, T<sub>2</sub>, T<sub>3</sub> and T<sub>4</sub> (<i>P</i><0.05). Compared with Group-F, the recovery time, intraoperative bradycardia and respiratory depression in Group-E were significantly lower (<i>P</i><0.05), and Christensen scores and the incidence of POFS decreased significantly on the 1st, 3rd, and 5th day after the operation (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Subanesthetic dose of esketamine combined with propofol can reduce POFS and postoperative adverse reactions in patients undergoing gastroenterological endoscopy.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of Medical Journals from Pakistan: Challenges and way Forward. 巴基斯坦医学期刊的可靠性:挑战与前进之路
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.10617
Shaukat Ali Jawaid, Jamshed Akhtar, Masood Jawaid
{"title":"Reliability of Medical Journals from Pakistan: Challenges and way Forward.","authors":"Shaukat Ali Jawaid, Jamshed Akhtar, Masood Jawaid","doi":"10.12669/pjms.40.8.10617","DOIUrl":"https://doi.org/10.12669/pjms.40.8.10617","url":null,"abstract":"","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan. 眼眶病变:巴基斯坦一家三级医院 27 年间 2068 个病例的系列观察。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9843
Asad Aslam Khan, Sidrah Latif, Muhammad Ismail A Khan, Imran Ahmad

Objective: To determine the relative frequency of orbital lesions based on the site of origin and histopathology at a Tertiary care hospital (Mayo Hospital, Lahore Pakistan) from 1996 till 2022 (27 years).

Methods: This descriptive case series included 2651 patients of all age groups presenting with orbital lesions who initially got enrolled at Institute of Ophthalmology Mayo Hospital, Lahore from 1996 till 2022. Of these, 583 patients left against medical advice. So, clinical data of 2068 patients were completely analyzed. Lesions were managed medically and/ or surgically. Final clinical diagnosis, with the help of histopathology, was used to classify the lesions.

Results: There were 1258 (60.9%) adults and 810 (39.1%) children, 1358 (65.66%) were neoplastic while 710 (34.33%) non-neoplastic lesions. Amongst the neoplastic lesions, 405 (29.8 %) were benign and 953 (70.2%) malignant. Primary orbital lesions were 1676 (81.04%), Secondary orbital lesions were 300 (14.51%), Endocrine/ hematopoietic reticulo-endothelial system lesions were 84 (4.06%) and Metastatic lesions from distant organs were 08 (0.39%).

Conclusion: Retinoblastoma, rhabdomyosarcoma, optic nerve gliomata were common in children. Pleomorphic adenoma & adenocystic carcinoma of lacrimal gland, cavernous hemangioma, optic nerve meningioma, neurofibroma, schwannoma, squamous cell carcinoma of eyelid, carcinoma of maxillary antrum and lymphomas were more common in adults.

目的根据 1996 年至 2022 年(27 年)期间一家三级医院(巴基斯坦拉合尔梅奥医院)眼眶病变的发病部位和组织病理学,确定眼眶病变的相对频率:该描述性病例系列包括 1996 年至 2022 年期间在拉合尔梅奥医院眼科研究所登记的 2651 名各年龄段眼眶病变患者。其中,583 名患者不听医嘱离开了医院。因此,我们对 2068 名患者的临床数据进行了全面分析。病变通过药物和/或手术进行治疗。最终的临床诊断在组织病理学的帮助下对病变进行分类:成人有 1258 例(60.9%),儿童有 810 例(39.1%),其中 1358 例(65.66%)为肿瘤性病变,710 例(34.33%)为非肿瘤性病变。在肿瘤性病变中,405 例(29.8%)为良性,953 例(70.2%)为恶性。原发性眼眶病变 1676 例(81.04%),继发性眼眶病变 300 例(14.51%),内分泌/造血网状内皮系统病变 84 例(4.06%),远处器官转移病变 08 例(0.39%):结论:视网膜母细胞瘤、横纹肌肉瘤、视神经胶质瘤在儿童中很常见。泪腺多形性腺瘤和腺囊肿癌、海绵状血管瘤、视神经脑膜瘤、神经纤维瘤、分裂瘤、眼睑鳞状细胞癌、上颌窦癌和淋巴瘤在成人中更为常见。
{"title":"Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan.","authors":"Asad Aslam Khan, Sidrah Latif, Muhammad Ismail A Khan, Imran Ahmad","doi":"10.12669/pjms.40.8.9843","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9843","url":null,"abstract":"<p><strong>Objective: </strong>To determine the relative frequency of orbital lesions based on the site of origin and histopathology at a Tertiary care hospital (Mayo Hospital, Lahore Pakistan) from 1996 till 2022 (27 years).</p><p><strong>Methods: </strong>This descriptive case series included 2651 patients of all age groups presenting with orbital lesions who initially got enrolled at Institute of Ophthalmology Mayo Hospital, Lahore from 1996 till 2022. Of these, 583 patients left against medical advice. So, clinical data of 2068 patients were completely analyzed. Lesions were managed medically and/ or surgically. Final clinical diagnosis, with the help of histopathology, was used to classify the lesions.</p><p><strong>Results: </strong>There were 1258 (60.9%) adults and 810 (39.1%) children, 1358 (65.66%) were neoplastic while 710 (34.33%) non-neoplastic lesions. Amongst the neoplastic lesions, 405 (29.8 %) were benign and 953 (70.2%) malignant. Primary orbital lesions were 1676 (81.04%), Secondary orbital lesions were 300 (14.51%), Endocrine/ hematopoietic reticulo-endothelial system lesions were 84 (4.06%) and Metastatic lesions from distant organs were 08 (0.39%).</p><p><strong>Conclusion: </strong>Retinoblastoma, rhabdomyosarcoma, optic nerve gliomata were common in children. Pleomorphic adenoma & adenocystic carcinoma of lacrimal gland, cavernous hemangioma, optic nerve meningioma, neurofibroma, schwannoma, squamous cell carcinoma of eyelid, carcinoma of maxillary antrum and lymphomas were more common in adults.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the shade matching accuracy among dental students through visual and instrumental methods. 通过视觉和仪器方法评估牙科学生的色调匹配准确性。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9491
Muhammad Adeel Ahmed

Objectives: To evaluate the shade selection accuracy of male dental students according to the three dimensions of color: value, hue, and chroma, using visual and instrumental shade selection methods under different lighting conditions.

Methods: This comparative cross-sectional study was instigated amongst 70 male 4th, 5th, and 6th years BDS students of the Dental Clinics Complex at King Faisal University, Saudi Arabia for a duration of two months. First, the principal investigator determined the shade of tooth 11 and 46 on patient utilizing the spectrophotometer after calibration. In the next step, students were asked to select the shade of same tooth 11 and 46 using VITA 3D-Master shade guide under clinic lightening condition and corrected light. The characteristics of the color such as hue, chroma and value were recorded. The Kruskal-Wallis test was applied to find the significant difference in shade selection between visual and instrumental methods with respect to academic years.

Results: The mean of the value of instrumental shade selection of tooth # 46 was slightly higher among 4th year students (4.41±0.73), than that of 5th year (3.72±1.02), and 6th year students (3.83±0.83), with a statistically significant difference among them (p= 0.024), indicating 6th year students selected darker shades. Additionally, a statistically significant relationship was noticed among 4th, 5th, and 6th year students with respect to the means of the chroma of 2.18 ±1.29, 2.92±1.11, and 3.13±1.10, respectively (p= 0.025).

Conclusion: The selection of posterior teeth shades was notably influenced by academic years, employing both instrumental and visual methods, while considering color parameters.

目的根据颜色的三个维度:价值、色调和色度,在不同的照明条件下使用视觉和仪器色调选择方法,评估牙科专业男生的色调选择准确性:这项横断面比较研究在沙特阿拉伯费萨尔国王大学牙科诊所综合楼的 70 名四年级、五年级和六年级 BDS 男生中进行,为期两个月。首先,主要研究人员利用校准后的分光光度计确定患者第 11 和 46 号牙齿的色调。下一步,要求学生使用 VITA 3D-Master 色调指南,在诊所照明条件和校正光线下选择 11 号和 46 号牙齿的色调。色调、色度和色值等颜色特征均被记录下来。采用 Kruskal-Wallis 检验找出视觉法和仪器法在不同学年选择牙色方面的显著差异:结果:四年级学生对 46 号牙齿的仪器色调选择平均值(4.41±0.73)略高于五年级学生(3.72±1.02)和六年级学生(3.83±0.83),两者之间的差异有统计学意义(P= 0.024),表明六年级学生选择了较深的色调。此外,四年级、五年级和六年级学生的色度均值分别为(2.18±1.29)、(2.92±1.11)和(3.13±1.10),差异有统计学意义(P= 0.025):在考虑颜色参数时,采用仪器和视觉方法,后牙色调的选择明显受学年的影响。
{"title":"Assessing the shade matching accuracy among dental students through visual and instrumental methods.","authors":"Muhammad Adeel Ahmed","doi":"10.12669/pjms.40.8.9491","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9491","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the shade selection accuracy of male dental students according to the three dimensions of color: value, hue, and chroma, using visual and instrumental shade selection methods under different lighting conditions.</p><p><strong>Methods: </strong>This comparative cross-sectional study was instigated amongst 70 male 4<sup>th</sup>, 5<sup>th</sup>, and 6<sup>th</sup> years BDS students of the Dental Clinics Complex at King Faisal University, Saudi Arabia for a duration of two months. First, the principal investigator determined the shade of tooth 11 and 46 on patient utilizing the spectrophotometer after calibration. In the next step, students were asked to select the shade of same tooth 11 and 46 using VITA 3D-Master shade guide under clinic lightening condition and corrected light. The characteristics of the color such as hue, chroma and value were recorded. The Kruskal-Wallis test was applied to find the significant difference in shade selection between visual and instrumental methods with respect to academic years.</p><p><strong>Results: </strong>The mean of the value of instrumental shade selection of tooth # 46 was slightly higher among 4<sup>th</sup> year students (4.41±0.73), than that of 5<sup>th</sup> year (3.72±1.02), and 6<sup>th</sup> year students (3.83±0.83), with a statistically significant difference among them (p= 0.024), indicating 6<sup>th</sup> year students selected darker shades. Additionally, a statistically significant relationship was noticed among 4<sup>th</sup>, 5<sup>th</sup>, and 6<sup>th</sup> year students with respect to the means of the chroma of 2.18 ±1.29, 2.92±1.11, and 3.13±1.10, respectively (<i>p</i>= 0.025).</p><p><strong>Conclusion: </strong>The selection of posterior teeth shades was notably influenced by academic years, employing both instrumental and visual methods, while considering color parameters.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of lived in experiences of healthcare workers during COVID-19 Pandemic in a tertiary Care hospital: A perspective from Pakistan. 一家三级护理医院的医护人员对 COVID-19 大流行期间生活经历的看法:来自巴基斯坦的视角。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9010
Bushra Ameer Saeed Awan, Shamaila Mohsin, Syed Fawad Mashhadi, Mohi Ud Din

Objective: This study aimed to explore the perceptions of frontline Healthcare Workers (HCWs) towards managing COVID-19 in Tertiary care hospital in Pakistan.

Method: This qualitative exploratory study was conducted from January to May 2021 at a Tertiary care hospital designated for COVID-19 patients in Rawalpindi Pakistan. Semi-structured in-depth interviews were conducted from twenty six HCWs. To acquire a sample that was diverse in terms of professional capacity, degree of experience and exposure, purposive sampling technique was used. After thematic analysis, themes were generated by identifying patterns among codes.

Results: Five themes emerged. All HCWs experienced significant amount of negative emotions including fear, uncertainty, imposing social distancing and workload. There were also positive experiences such as rewarding, call of duty and professional growth. HCWs experiences related to personal protective equipment (PPE) were communication issues, physical and dermatological issues, reuse and working confidently while wearing PPE. HCWs were buoyed by cooperation and facilitation, trainings and health education from administration. Coping mechanisms were used such as seeking team support, adjusting cognition to deal with reality and resorting to religion.

Conclusion: Negative emotions predominated in the beginning and positive emotions emerged gradually. PPE and administrative support played significant role. HCWs' mental health was maintained in part by their self-coping styles. The findings of this study can be employed to inform and enhance future pandemic response initiatives.

研究目的本研究旨在探讨巴基斯坦三级医院一线医护人员(HCWs)对管理 COVID-19 的看法:这项定性探索性研究于 2021 年 1 月至 5 月在巴基斯坦拉瓦尔品第一家指定收治 COVID-19 患者的三级医院进行。对 26 名医护人员进行了半结构化深度访谈。为了获得在专业能力、经验和接触程度方面多样化的样本,采用了目的性抽样技术。在进行主题分析后,通过识别代码之间的模式产生了主题:结果:产生了五个主题。所有医护人员都经历了大量负面情绪,包括恐惧、不确定性、强加的社会疏离感和工作量。同时也有积极的体验,如收获、使命感和专业成长。与个人防护设备(PPE)有关的经历包括沟通问题、身体和皮肤问题、重复使用以及在穿戴个人防护设备的情况下自信地工作。管理部门的合作与促进、培训和健康教育为医务工作者提供了动力。他们还使用了一些应对机制,如寻求团队支持、调整认知以应对现实和诉诸宗教:结论:开始时消极情绪占主导地位,后来逐渐出现积极情绪。个人防护设备和行政支持发挥了重要作用。高危产妇的心理健康在一定程度上得益于她们的自我应对方式。本研究的结果可用于指导和加强未来的大流行应对措施。
{"title":"Perceptions of lived in experiences of healthcare workers during COVID-19 Pandemic in a tertiary Care hospital: A perspective from Pakistan.","authors":"Bushra Ameer Saeed Awan, Shamaila Mohsin, Syed Fawad Mashhadi, Mohi Ud Din","doi":"10.12669/pjms.40.8.9010","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9010","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore the perceptions of frontline Healthcare Workers (HCWs) towards managing COVID-19 in Tertiary care hospital in Pakistan.</p><p><strong>Method: </strong>This qualitative exploratory study was conducted from January to May 2021 at a Tertiary care hospital designated for COVID-19 patients in Rawalpindi Pakistan. Semi-structured in-depth interviews were conducted from twenty six HCWs. To acquire a sample that was diverse in terms of professional capacity, degree of experience and exposure, purposive sampling technique was used. After thematic analysis, themes were generated by identifying patterns among codes.</p><p><strong>Results: </strong>Five themes emerged. All HCWs experienced significant amount of negative emotions including fear, uncertainty, imposing social distancing and workload. There were also positive experiences such as rewarding, call of duty and professional growth. HCWs experiences related to personal protective equipment (PPE) were communication issues, physical and dermatological issues, reuse and working confidently while wearing PPE. HCWs were buoyed by cooperation and facilitation, trainings and health education from administration. Coping mechanisms were used such as seeking team support, adjusting cognition to deal with reality and resorting to religion.</p><p><strong>Conclusion: </strong>Negative emotions predominated in the beginning and positive emotions emerged gradually. PPE and administrative support played significant role. HCWs' mental health was maintained in part by their self-coping styles. The findings of this study can be employed to inform and enhance future pandemic response initiatives.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effects of losartan potassium and benazepril in the treatment of hypertensive patients with insulin resistance. 比较洛沙坦钾和贝那普利治疗胰岛素抵抗高血压患者的效果。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9896
Tingting Ma, Yangui Wang, Haixia Liu, Tao Wang, Yue Zhao, Yao Li

Objective: To compare the efficacy of losartan potassium (LP) and benazepril in the treatment of hypertensive patients with insulin resistance (IR).

Methods: This is a retrospective analysis of the clinical data of 155 hypertensive patients with IR admitted to Shanghai Pudong New Area People's Hospital from March 2021 to March 2023. Of these 76 received LP treatment (LP group), and 79 received benazepril treatment (benazepril group). Blood pressure levels, blood glucose and insulin levels, treatment efficacy, and incidence of adverse reactions before and after the treatment in both groups were compared.

Results: After the treatment, diastolic and systolic blood pressure in the two groups significantly decreased compared to pre-treatment levels (P<0.05), with no significant difference between the two groups (P>0.05). After the treatment, levels of fasting plasma glucose (FPG), 2-hours plasma glucose (2hPG), fasting insulin (FINS), 2-hours insulin (2hINS), and insulin sensitivity index (ISI) in both groups significantly decreased compared to pre-treatment levels (P<0.05), with no significant difference between the two groups (P>0.05). There was no significant difference in the total efficacy and the incidence of adverse reactions between the two groups (P>0.05).

Conclusions: The efficacy of LP and benazepril in treating hypertension with IR is equivalent. Both are safe and can effectively lower blood sugar and insulin levels, alleviate IR, and lower blood pressure.

目的比较洛沙坦钾(LP)和贝那普利治疗胰岛素抵抗(IR)高血压患者的疗效:这是一项回顾性分析,研究对象是2021年3月至2023年3月期间在上海市浦东新区人民医院住院治疗的155例高血压IR患者。其中 76 人接受 LP 治疗(LP 组),79 人接受贝那普利治疗(贝那普利组)。比较两组患者治疗前后的血压水平、血糖和胰岛素水平、疗效和不良反应发生率:结果:治疗后,两组患者的舒张压和收缩压与治疗前相比均明显下降(PP>0.05)。治疗后,两组患者的空腹血浆葡萄糖(FPG)、2 小时血浆葡萄糖(2hPG)、空腹胰岛素(FINS)、2 小时胰岛素(2hINS)和胰岛素敏感性指数(ISI)与治疗前相比均明显下降(PP>0.05)。两组的总疗效和不良反应发生率无明显差异(P>0.05):结论:LP 和贝那普利治疗高血压合并 IR 的疗效相当。结论:LP 和贝那普利治疗高血压合并 IR 的疗效相当,两者都安全,都能有效降低血糖和胰岛素水平,缓解 IR,降低血压。
{"title":"Comparison of the effects of losartan potassium and benazepril in the treatment of hypertensive patients with insulin resistance.","authors":"Tingting Ma, Yangui Wang, Haixia Liu, Tao Wang, Yue Zhao, Yao Li","doi":"10.12669/pjms.40.8.9896","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9896","url":null,"abstract":"<p><strong>Objective: </strong>To compare the efficacy of losartan potassium (LP) and benazepril in the treatment of hypertensive patients with insulin resistance (IR).</p><p><strong>Methods: </strong>This is a retrospective analysis of the clinical data of 155 hypertensive patients with IR admitted to Shanghai Pudong New Area People's Hospital from March 2021 to March 2023. Of these 76 received LP treatment (LP group), and 79 received benazepril treatment (benazepril group). Blood pressure levels, blood glucose and insulin levels, treatment efficacy, and incidence of adverse reactions before and after the treatment in both groups were compared.</p><p><strong>Results: </strong>After the treatment, diastolic and systolic blood pressure in the two groups significantly decreased compared to pre-treatment levels (<i>P</i><0.05), with no significant difference between the two groups (<i>P</i>>0.05). After the treatment, levels of fasting plasma glucose (FPG), 2-hours plasma glucose (2hPG), fasting insulin (FINS), 2-hours insulin (2hINS), and insulin sensitivity index (ISI) in both groups significantly decreased compared to pre-treatment levels (<i>P</i><0.05), with no significant difference between the two groups (<i>P</i>>0.05). There was no significant difference in the total efficacy and the incidence of adverse reactions between the two groups (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>The efficacy of LP and benazepril in treating hypertension with IR is equivalent. Both are safe and can effectively lower blood sugar and insulin levels, alleviate IR, and lower blood pressure.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caesarean Section frequency in Nulliparous Women induced at 39 weeks versus conventional management: An open label random allocation study. 39 周引产与常规处理相比,无阴道妇女的剖腹产频率:一项开放标签随机分配研究。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.9099
Erum Majid, Bader Faiyaz Zuberi, Kanwal Gul, Hira Jam, Gul Haseena

Objective: To compare frequency of caesarean section in singleton primary-para women induced at 39 week and its comparison with conventional management. The other objective was comparison of perinatal and neonatal outcomes.

Method: Open random allocation study was conducted at Gynae/Obst Department JPMC during period from 1st June 2022 to 30th September 2023. Primiparous women with singleton pregnancy without risk factors with gestational age 38 weeks 0 days to 38 weeks six days attending the anti-natal clinic offered to participate after consent. Non-probability convenience sampling method was used for induction. Randomization was done using random number table into one of the two groups, Group-A in which induction was done at 39 weeks while in Group-B induction was done conventionally. Mean age ±SD, gestational age and delivery time was calculated and compared by Student's t test. Frequency of CS, perinatal and neonatal outcomes was compared by χ2 test.

Results: Eighty-two women were inducted in Group-A and eighty-five in Group-B. The mean delivery time in Group-A was significantly more at 8.12±2.77 hours while in Group-B was 7.0±2.62 hours (p = .005). Frequency of CS between two groups was not statistically significant, it was 5 (6.1%) in Group-A and 2 (2.4%) in Group-B (p = 0.412). No significant difference in frequency of NICU admission was seen, in Group-A 8.54% babies were admitted to NICU while in Group-B 16.47% were admitted to NICU (p = 0.122).

Conclusion: No significant difference was observed in frequencies of CS, Foetal, Neonatal, and Maternal outcomes.

目的比较 39 周引产的单胎初产妇剖腹产的频率,以及与常规处理方法的比较。另一个目的是比较围产期和新生儿的预后:方法:2022 年 6 月 1 日至 2023 年 9 月 30 日期间,在 JPMC 妇产科进行了开放式随机分配研究。无风险因素的单胎妊娠初产妇,孕龄为 38 周 0 天至 38 周 6 天,在征得同意后前往产前门诊就诊。诱导采用非概率方便抽样法。使用随机数字表随机分为两组,A 组在 39 周时进行引产,B 组则按常规进行引产。计算平均年龄(±SD)、胎龄和分娩时间,并通过学生 t 检验进行比较。CS 发生率、围产期和新生儿结局通过 χ2 检验进行比较:结果:A 组有 82 名产妇,B 组有 85 名产妇。A 组的平均分娩时间为(8.12±2.77)小时,明显高于 B 组(7.0±2.62)小时(P = .005)。两组间的 CS 发生率无统计学意义,A 组为 5(6.1%)次,B 组为 2(2.4%)次(P = 0.412)。入住新生儿重症监护室的频率无明显差异,A 组有 8.54% 的婴儿入住新生儿重症监护室,而 B 组有 16.47% 的婴儿入住新生儿重症监护室(P = 0.122):结论:CS、胎儿、新生儿和产妇结局的发生率无明显差异。
{"title":"Caesarean Section frequency in Nulliparous Women induced at 39 weeks versus conventional management: An open label random allocation study.","authors":"Erum Majid, Bader Faiyaz Zuberi, Kanwal Gul, Hira Jam, Gul Haseena","doi":"10.12669/pjms.40.8.9099","DOIUrl":"https://doi.org/10.12669/pjms.40.8.9099","url":null,"abstract":"<p><strong>Objective: </strong>To compare frequency of caesarean section in singleton primary-para women induced at 39 week and its comparison with conventional management. The other objective was comparison of perinatal and neonatal outcomes.</p><p><strong>Method: </strong>Open random allocation study was conducted at Gynae/Obst Department JPMC during period from 1<sup>st</sup> June 2022 to 30<sup>th</sup> September 2023. Primiparous women with singleton pregnancy without risk factors with gestational age 38 weeks 0 days to 38 weeks six days attending the anti-natal clinic offered to participate after consent. Non-probability convenience sampling method was used for induction. Randomization was done using random number table into one of the two groups, Group-A in which induction was done at 39 weeks while in Group-B induction was done conventionally. Mean age ±SD, gestational age and delivery time was calculated and compared by Student's t test. Frequency of CS, perinatal and neonatal outcomes was compared by χ<sup>2</sup> test.</p><p><strong>Results: </strong>Eighty-two women were inducted in Group-A and eighty-five in Group-B. The mean delivery time in Group-A was significantly more at 8.12±2.77 hours while in Group-B was 7.0±2.62 hours (<i>p</i> = .005). Frequency of CS between two groups was not statistically significant, it was 5 (6.1%) in Group-A and 2 (2.4%) in Group-B (<i>p</i> = 0.412). No significant difference in frequency of NICU admission was seen, in Group-A 8.54% babies were admitted to NICU while in Group-B 16.47% were admitted to NICU (<i>p</i> = 0.122).</p><p><strong>Conclusion: </strong>No significant difference was observed in frequencies of CS, Foetal, Neonatal, and Maternal outcomes.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination. 土耳其一家 COVID-19 医院中感染 SARS-CoV-2 的医护人员的特征:同源疫苗接种与异源疫苗接种。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.12669/pjms.40.8.8455
Isıl Deniz Alıravcı, Yusuf Haydar Ertekin, Gamze Can, Sevil Alkan

Objective: Given the limited studies on types of vaccination and infection rates among health care workers (HCWs) in Türkiye, we analyzed the demographic, clinical, and vaccination characteristics as well as the attitudes of HCWs who have been infected with COVID-19.

Methods: We retrospectively analyzed demographic and clinical data on breakthrough COVID-19 infections in HCWs from hospital surveillance data collected between April 5, 2020, and November 1, 2022. The comparison was based on four subgroups that consisted of unvaccinated, one-shot-vaccinated, homologous vaccinated, and heterologous vaccinated individuals. Participants who received various combinations of Sinovac/CoronaVac and/or BioNTech/Pfizer vaccines were compared for detection of COVID-19.

Results: During a 33-month period of 744 HCWs who contracted COVID-19, women (65.3%) and nurses (28.9%) were the most affected, followed by doctors (25.8%). Of the infected HCWs, only 1.3% required hospitalization, 0.3% required ICU support, and 98.4% were outpatients. By vaccination status, 143 of the HCWs (19.2%) were unvaccinated, 292 (39.2%) were homologously vaccinated, 294 (39.5%) were heterologously vaccinated, 15 (2%) received a single shot, 206 (27.7%) received two shots, and 165 (22.2%) received three shots. All HCWs contracted COVID-19 at a mean of 134-days (range:1-539) after vaccination. While the proportions of homologously and heterologously vaccinated HCWs were similar, the time elapsed from vaccination to contracting COVID-19 varied (mean 143.4±106.7 vs.126.4±82.43 days).

Conclusions: Among both outpatients and inpatients with COVID-19, women HCWs outnumbered men HCWs. HCWs who received homologous vaccination contracted COVID-19 later than those who received heterologous vaccination.

目的鉴于有关土耳其医护人员(HCWs)疫苗接种类型和感染率的研究有限,我们分析了感染 COVID-19 的医护人员的人口统计、临床和疫苗接种特征以及态度:我们回顾性分析了 2020 年 4 月 5 日至 2022 年 11 月 1 日期间收集的医院监测数据中有关高危工人突破性 COVID-19 感染的人口统计学和临床数据。比较基于四个亚组,包括未接种疫苗者、一次性接种疫苗者、同种疫苗者和异种疫苗者。对接种了 Sinovac/CoronaVac 和/或 BioNTech/Pfizer 疫苗不同组合的参与者进行了 COVID-19 检测比较:结果:在为期33个月的744名感染COVID-19的医护人员中,女性(65.3%)和护士(28.9%)感染率最高,其次是医生(25.8%)。在受感染的医护人员中,只有 1.3% 需要住院治疗,0.3% 需要重症监护室支持,98.4% 是门诊病人。根据疫苗接种情况,143 名医务工作者(19.2%)未接种疫苗,292 名(39.2%)接种了同源疫苗,294 名(39.5%)接种了异源疫苗,15 名(2%)接种了一针,206 名(27.7%)接种了两针,165 名(22.2%)接种了三针。所有高危工人平均在接种后 134 天(范围:1-539)感染 COVID-19。虽然接种同源疫苗和异源疫苗的医护人员比例相似,但从接种疫苗到感染 COVID-19 的时间却各不相同(平均为 143.4±106.7 天 vs. 126.4±82.43 天):结论:在门诊和住院COVID-19患者中,女性HCW多于男性HCW。接种同种疫苗的医护人员比接种异种疫苗的医护人员更晚感染 COVID-19。
{"title":"Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination.","authors":"Isıl Deniz Alıravcı, Yusuf Haydar Ertekin, Gamze Can, Sevil Alkan","doi":"10.12669/pjms.40.8.8455","DOIUrl":"https://doi.org/10.12669/pjms.40.8.8455","url":null,"abstract":"<p><strong>Objective: </strong>Given the limited studies on types of vaccination and infection rates among health care workers (HCWs) in Türkiye, we analyzed the demographic, clinical, and vaccination characteristics as well as the attitudes of HCWs who have been infected with COVID-19.</p><p><strong>Methods: </strong>We retrospectively analyzed demographic and clinical data on breakthrough COVID-19 infections in HCWs from hospital surveillance data collected between April 5, 2020, and November 1, 2022. The comparison was based on four subgroups that consisted of unvaccinated, one-shot-vaccinated, homologous vaccinated, and heterologous vaccinated individuals. Participants who received various combinations of Sinovac/CoronaVac and/or BioNTech/Pfizer vaccines were compared for detection of COVID-19.</p><p><strong>Results: </strong>During a 33-month period of 744 HCWs who contracted COVID-19, women (65.3%) and nurses (28.9%) were the most affected, followed by doctors (25.8%). Of the infected HCWs, only 1.3% required hospitalization, 0.3% required ICU support, and 98.4% were outpatients. By vaccination status, 143 of the HCWs (19.2%) were unvaccinated, 292 (39.2%) were homologously vaccinated, 294 (39.5%) were heterologously vaccinated, 15 (2%) received a single shot, 206 (27.7%) received two shots, and 165 (22.2%) received three shots. All HCWs contracted COVID-19 at a mean of 134-days (range:1-539) after vaccination. While the proportions of homologously and heterologously vaccinated HCWs were similar, the time elapsed from vaccination to contracting COVID-19 varied (mean 143.4±106.7 vs.126.4±82.43 days).</p><p><strong>Conclusions: </strong>Among both outpatients and inpatients with COVID-19, women HCWs outnumbered men HCWs. HCWs who received homologous vaccination contracted COVID-19 later than those who received heterologous vaccination.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11395381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142293073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pakistan Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1